1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Retinal Dystrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Gene Therapy Treatment 1.2.3 Symptomatic Treatment 1.3 Market by Application 1.3.1 Global Retinal Dystrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Retinal Dystrophy Treatment Market Perspective (2016-2027) 2.2 Retinal Dystrophy Treatment Growth Trends by Regions 2.2.1 Retinal Dystrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Retinal Dystrophy Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Retinal Dystrophy Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Retinal Dystrophy Treatment Industry Dynamic 2.3.1 Retinal Dystrophy Treatment Market Trends 2.3.2 Retinal Dystrophy Treatment Market Drivers 2.3.3 Retinal Dystrophy Treatment Market Challenges 2.3.4 Retinal Dystrophy Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Retinal Dystrophy Treatment Players by Revenue 3.1.1 Global Top Retinal Dystrophy Treatment Players by Revenue (2016-2021) 3.1.2 Global Retinal Dystrophy Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Retinal Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Retinal Dystrophy Treatment Revenue 3.4 Global Retinal Dystrophy Treatment Market Concentration Ratio 3.4.1 Global Retinal Dystrophy Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Retinal Dystrophy Treatment Revenue in 2020 3.5 Retinal Dystrophy Treatment Key Players Head office and Area Served 3.6 Key Players Retinal Dystrophy Treatment Product Solution and Service 3.7 Date of Enter into Retinal Dystrophy Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Retinal Dystrophy Treatment Breakdown Data by Type 4.1 Global Retinal Dystrophy Treatment Historic Market Size by Type (2016-2021) 4.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2022-2027) 5 Retinal Dystrophy Treatment Breakdown Data by Application 5.1 Global Retinal Dystrophy Treatment Historic Market Size by Application (2016-2021) 5.2 Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Retinal Dystrophy Treatment Market Size (2016-2027) 6.2 North America Retinal Dystrophy Treatment Market Size by Type 6.2.1 North America Retinal Dystrophy Treatment Market Size by Type (2016-2021) 6.2.2 North America Retinal Dystrophy Treatment Market Size by Type (2022-2027) 6.2.3 North America Retinal Dystrophy Treatment Market Size by Type (2016-2027) 6.3 North America Retinal Dystrophy Treatment Market Size by Application 6.3.1 North America Retinal Dystrophy Treatment Market Size by Application (2016-2021) 6.3.2 North America Retinal Dystrophy Treatment Market Size by Application (2022-2027) 6.3.3 North America Retinal Dystrophy Treatment Market Size by Application (2016-2027) 6.4 North America Retinal Dystrophy Treatment Market Size by Country 6.4.1 North America Retinal Dystrophy Treatment Market Size by Country (2016-2021) 6.4.2 North America Retinal Dystrophy Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Retinal Dystrophy Treatment Market Size (2016-2027) 7.2 Europe Retinal Dystrophy Treatment Market Size by Type 7.2.1 Europe Retinal Dystrophy Treatment Market Size by Type (2016-2021) 7.2.2 Europe Retinal Dystrophy Treatment Market Size by Type (2022-2027) 7.2.3 Europe Retinal Dystrophy Treatment Market Size by Type (2016-2027) 7.3 Europe Retinal Dystrophy Treatment Market Size by Application 7.3.1 Europe Retinal Dystrophy Treatment Market Size by Application (2016-2021) 7.3.2 Europe Retinal Dystrophy Treatment Market Size by Application (2022-2027) 7.3.3 Europe Retinal Dystrophy Treatment Market Size by Application (2016-2027) 7.4 Europe Retinal Dystrophy Treatment Market Size by Country 7.4.1 Europe Retinal Dystrophy Treatment Market Size by Country (2016-2021) 7.4.2 Europe Retinal Dystrophy Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Retinal Dystrophy Treatment Market Size (2016-2027) 8.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type 8.2.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application 8.3.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region 8.4.1 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Retinal Dystrophy Treatment Market Size (2016-2027) 9.2 Latin America Retinal Dystrophy Treatment Market Size by Type 9.2.1 Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Retinal Dystrophy Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2027) 9.3 Latin America Retinal Dystrophy Treatment Market Size by Application 9.3.1 Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Retinal Dystrophy Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2027) 9.4 Latin America Retinal Dystrophy Treatment Market Size by Country 9.4.1 Latin America Retinal Dystrophy Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Retinal Dystrophy Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Retinal Dystrophy Treatment Market Size (2016-2027) 10.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type 10.2.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application 10.3.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country 10.4.1 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Spark Therapeutics (Roche) 11.1.1 Spark Therapeutics (Roche) Company Details 11.1.2 Spark Therapeutics (Roche) Business Overview 11.1.3 Spark Therapeutics (Roche) Retinal Dystrophy Treatment Introduction 11.1.4 Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.1.5 Spark Therapeutics (Roche) Recent Development 11.2 Novartis AG 11.2.1 Novartis AG Company Details 11.2.2 Novartis AG Business Overview 11.2.3 Novartis AG Retinal Dystrophy Treatment Introduction 11.2.4 Novartis AG Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.2.5 Novartis AG Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Retinal Dystrophy Treatment Introduction 11.3.4 GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.3.5 GlaxoSmithKline Recent Development 11.4 Applied Genetic Technologies Corporation 11.4.1 Applied Genetic Technologies Corporation Company Details 11.4.2 Applied Genetic Technologies Corporation Business Overview 11.4.3 Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Introduction 11.4.4 Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.4.5 Applied Genetic Technologies Corporation Recent Development 11.5 Oxford BioMedica 11.5.1 Oxford BioMedica Company Details 11.5.2 Oxford BioMedica Business Overview 11.5.3 Oxford BioMedica Retinal Dystrophy Treatment Introduction 11.5.4 Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.5.5 Oxford BioMedica Recent Development 11.6 Biogen 11.6.1 Biogen Company Details 11.6.2 Biogen Business Overview 11.6.3 Biogen Retinal Dystrophy Treatment Introduction 11.6.4 Biogen Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.6.5 Biogen Recent Development 11.7 HORAMA S.A. 11.7.1 HORAMA S.A. Company Details 11.7.2 HORAMA S.A. Business Overview 11.7.3 HORAMA S.A. Retinal Dystrophy Treatment Introduction 11.7.4 HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.7.5 HORAMA S.A. Recent Development 11.8 MeiraGTx Limited 11.8.1 MeiraGTx Limited Company Details 11.8.2 MeiraGTx Limited Business Overview 11.8.3 MeiraGTx Limited Retinal Dystrophy Treatment Introduction 11.8.4 MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.8.5 MeiraGTx Limited Recent Development 11.9 Novelion Therapeutics 11.9.1 Novelion Therapeutics Company Details 11.9.2 Novelion Therapeutics Business Overview 11.9.3 Novelion Therapeutics Retinal Dystrophy Treatment Introduction 11.9.4 Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.9.5 Novelion Therapeutics Recent Development 11.10 IVERIC bio 11.10.1 IVERIC bio Company Details 11.10.2 IVERIC bio Business Overview 11.10.3 IVERIC bio Retinal Dystrophy Treatment Introduction 11.10.4 IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.10.5 IVERIC bio Recent Development 11.11 Reflection Biotechnologies 11.11.1 Reflection Biotechnologies Company Details 11.11.2 Reflection Biotechnologies Business Overview 11.11.3 Reflection Biotechnologies Retinal Dystrophy Treatment Introduction 11.11.4 Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2016-2021) 11.11.5 Reflection Biotechnologies Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Retinal Dystrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Gene Therapy Treatment Table 3. Key Players of Symptomatic Treatment Table 4. Global Retinal Dystrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Retinal Dystrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Retinal Dystrophy Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Retinal Dystrophy Treatment Market Share by Regions (2016-2021) Table 8. Global Retinal Dystrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Retinal Dystrophy Treatment Market Share by Regions (2022-2027) Table 10. Retinal Dystrophy Treatment Market Trends Table 11. Retinal Dystrophy Treatment Market Drivers Table 12. Retinal Dystrophy Treatment Market Challenges Table 13. Retinal Dystrophy Treatment Market Restraints Table 14. Global Retinal Dystrophy Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Retinal Dystrophy Treatment Market Share by Players (2016-2021) Table 16. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Dystrophy Treatment as of 2020) Table 17. Ranking of Global Top Retinal Dystrophy Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Retinal Dystrophy Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Retinal Dystrophy Treatment Product Solution and Service Table 21. Date of Enter into Retinal Dystrophy Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Retinal Dystrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Retinal Dystrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Retinal Dystrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Retinal Dystrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Retinal Dystrophy Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Retinal Dystrophy Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Retinal Dystrophy Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Retinal Dystrophy Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Spark Therapeutics (Roche) Company Details Table 62. Spark Therapeutics (Roche) Business Overview Table 63. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Product Table 64. Spark Therapeutics (Roche) Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 65. Spark Therapeutics (Roche) Recent Development Table 66. Novartis AG Company Details Table 67. Novartis AG Business Overview Table 68. Novartis AG Retinal Dystrophy Treatment Product Table 69. Novartis AG Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 70. Novartis AG Recent Development Table 71. GlaxoSmithKline Company Details Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Retinal Dystrophy Treatment Product Table 74. GlaxoSmithKline Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 75. GlaxoSmithKline Recent Development Table 76. Applied Genetic Technologies Corporation Company Details Table 77. Applied Genetic Technologies Corporation Business Overview Table 78. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Product Table 79. Applied Genetic Technologies Corporation Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 80. Applied Genetic Technologies Corporation Recent Development Table 81. Oxford BioMedica Company Details Table 82. Oxford BioMedica Business Overview Table 83. Oxford BioMedica Retinal Dystrophy Treatment Product Table 84. Oxford BioMedica Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 85. Oxford BioMedica Recent Development Table 86. Biogen Company Details Table 87. Biogen Business Overview Table 88. Biogen Retinal Dystrophy Treatment Product Table 89. Biogen Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 90. Biogen Recent Development Table 91. HORAMA S.A. Company Details Table 92. HORAMA S.A. Business Overview Table 93. HORAMA S.A. Retinal Dystrophy Treatment Product Table 94. HORAMA S.A. Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 95. HORAMA S.A. Recent Development Table 96. MeiraGTx Limited Company Details Table 97. MeiraGTx Limited Business Overview Table 98. MeiraGTx Limited Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 99. MeiraGTx Limited Recent Development Table 100. Novelion Therapeutics Company Details Table 101. Novelion Therapeutics Business Overview Table 102. Novelion Therapeutics Retinal Dystrophy Treatment Product Table 103. Novelion Therapeutics Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 104. Novelion Therapeutics Recent Development Table 105. IVERIC bio Company Details Table 106. IVERIC bio Business Overview Table 107. IVERIC bio Retinal Dystrophy Treatment Product Table 108. IVERIC bio Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 109. IVERIC bio Recent Development Table 110. Reflection Biotechnologies Company Details Table 111. Reflection Biotechnologies Business Overview Table 112. Reflection Biotechnologies Retinal Dystrophy Treatment Product Table 113. Reflection Biotechnologies Revenue in Retinal Dystrophy Treatment Business (2016-2021) & (US$ Million) Table 114. Reflection Biotechnologies Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinal Dystrophy Treatment Market Share by Type: 2020 VS 2027 Figure 2. Gene Therapy Treatment Features Figure 3. Symptomatic Treatment Features Figure 4. Global Retinal Dystrophy Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Specialty Clinics Case Studies Figure 7. Others Case Studies Figure 8. Retinal Dystrophy Treatment Report Years Considered Figure 9. Global Retinal Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Retinal Dystrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Retinal Dystrophy Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Retinal Dystrophy Treatment Market Share by Regions (2022-2027) Figure 13. Global Retinal Dystrophy Treatment Market Share by Players in 2020 Figure 14. Global Top Retinal Dystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Dystrophy Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Retinal Dystrophy Treatment Revenue in 2020 Figure 16. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Retinal Dystrophy Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Retinal Dystrophy Treatment Market Share by Type (2016-2027) Figure 20. North America Retinal Dystrophy Treatment Market Share by Application (2016-2027) Figure 21. North America Retinal Dystrophy Treatment Market Share by Country (2016-2027) Figure 22. United States Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Retinal Dystrophy Treatment Market Share by Type (2016-2027) Figure 26. Europe Retinal Dystrophy Treatment Market Share by Application (2016-2027) Figure 27. Europe Retinal Dystrophy Treatment Market Share by Country (2016-2027) Figure 28. Germany Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Retinal Dystrophy Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Retinal Dystrophy Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Retinal Dystrophy Treatment Market Share by Region (2016-2027) Figure 38. China Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Retinal Dystrophy Treatment Market Share by Type (2016-2027) Figure 46. Latin America Retinal Dystrophy Treatment Market Share by Application (2016-2027) Figure 47. Latin America Retinal Dystrophy Treatment Market Share by Country (2016-2027) Figure 48. Mexico Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Retinal Dystrophy Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Retinal Dystrophy Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Retinal Dystrophy Treatment Market Share by Country (2016-2027) Figure 54. Turkey Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Retinal Dystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Spark Therapeutics (Roche) Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 58. Novartis AG Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 59. GlaxoSmithKline Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 60. Applied Genetic Technologies Corporation Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 61. Oxford BioMedica Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 62. Biogen Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 63. HORAMA S.A. Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 64. MeiraGTx Limited Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 65. Novelion Therapeutics Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 66. IVERIC bio Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 67. Reflection Biotechnologies Revenue Growth Rate in Retinal Dystrophy Treatment Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Spark Therapeutics (Roche) Novartis AG GlaxoSmithKline Applied Genetic Technologies Corporation Oxford BioMedica Biogen HORAMA S.A. MeiraGTx Limited Novelion Therapeutics IVERIC bio Reflection Biotechnologies